Cyclic AMP signaling pathway modulates susceptibility of Candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 10, 2003, Pages 3195-3201

  Jain, Pooja ^a   Akula, Indira ^a   Edlind, Thomas ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CARRIER PROTEIN; CASPOFUNGIN; CDR1 PROTEIN; CELL CYCLE PROTEIN; CYCLIC AMP; FENPROPIMORPH; FLUCONAZOLE; FUNGAL PROTEIN; GENE PRODUCT; GLYCOPROTEIN P; IMINE; IMMUNOLOGICAL ADJUVANT; ITRACONAZOLE; MICONAZOLE; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; NAPHTHALENE DERIVATIVE; PROTEIN CAP1; PROTEIN CDC35; PROTEIN CYR1; PROTEIN SRV2; PROTEIN SYNTHESIS INHIBITOR; PYRROLE DERIVATIVE; STEROL; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CANDIDA; CANDIDA ALBICANS; CDR1 GENE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS MUTANT; GENE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATION; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; UPREGULATION; VIRULENCE;

ADENYLATE CYCLASE; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CYCLIC AMP; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENOTYPE; IMINES; ITRACONAZOLE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; NAPHTHALENES; PROTEIN SYNTHESIS INHIBITORS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; STEROLS; UP-REGULATION;

EID: 0141924879     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.10.3195-3201.2003     Document Type: Article

References (36)

1. Bahn, Y.-S., and P. Sundstrom. 2001. CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans. J. Bacteriol. 183:3211-3223.
2. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1265.
3. Barns, S. M., D. J. Lane, M. L. Sogin, C. Bibeau, and W. G. Weisburg. 1991. Evolutionary relationships among pathogenic Candida species and relatives. J. Bacteriol. 173:2250-2255.
4. Boguslawski, G., and J. O. Polazzi. 1987. Complete nucleotide sequence of a gene conferring polymyxin B resistance on yeast: similarity of the predicted polypeptide to protein kinases. Proc. Natl. Acad. Sci. USA 84:5848-5852.
5. Colombo, S., P. Ma, L. Cauwenberg, J. Winderickx, M. Crauwels, A. Teunissen, D. Nauwelaers, J. H. de Winde, M.-F. Gorwa, D. Colavizza, and J. M. Thevelein. 1998. Involvement of distinct G-proteins Gpa2 and Ras1 in glucose- and intracellular acidification-induced CAMP signaling in the yeast S. cerevisiae. EMBO J. 17:3326-3341.
6. Crechet, J.-B., E. Jacquet, A. Bernardi, and A. Parmeggiani. 2000. Analysis of the role of the hypervariable region of yeast Ras2p and its farnesylation in the interaction with exchange factors and adenyl cyclase. J. Biol. Chem. 275:17754-17761.
7. Cruz, M. C., A. L. Goldstein, J. R. Blankenship, M. Del Poeta, D. Davis, M. E. Cardenas, J. R. Perfect, J. H. McCusker, and J. Heitman. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:546-559.
8. De Backer, M. D., T. Ilyina, X.-J. Ma, S. Vandoninck, W. H. M. L. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
9. Dimster-Denk, D., J. Rine, J. Phillips, S. Scherer, P. Cundiff, K. DeBord, D. Gilliland, S. Hickman, A. Jarvis, L. Tong, and M. Ashby. 1999. Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the genome reporter matrix. J. Lipid Res. 40:850-860.
10. D'Souza, C. A., and J. Heitman. 2001. Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol. Rev. 25:349-364.
11. Edlind, T., L. Smith, K. Henry, S. Katiyar, and J. Nickels. 2002. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signaling. Mol. Microbiol. 46:257-268.
12. Fedor-Chaiken, M., R. J. Deschenes, and J. R. Broach. 1990. SRV2, a gene required for RAS activation of adenylate cyclase in yeast. Cell 61:329-340.
13. Field, J., A. Vojtek, R. Ballester, G. Bolger, J. Colicelli, K. Ferguson, J. Gerst, T. Kataoka, T. Michaeli, and S. Powers. 1990. Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein. Cell 61:319-327.
14. Franz, R., S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhauser. 1998. Multiple mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072.
15. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517.
16. Guellaen, G., J. L. Mahu, P. Mavier, P. Berthelot, and J. Hanoune. 1977. RMI 12330 A, an inhibitor of adenylate cyclase in rat liver. Biochim. Biophys. Acta 13:465-475.
17. Henry, K. W., J. T. Nickels, and T. D. Edlind. 2002. ROX1 and ERG regulation in Saccharomyces cerevisiae: implications for antifungal susceptibility. Eukaryot. Cell 1:1041-1044.
18. Hernaez, M. L., C. Gil, J. Pla, and C. Nombela. 1998. Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals. Yeast 14:517-526.
19. Hubberstey, A. V., and E. P. Mottillo. 2002. Cyclase-associated proteins: capacity for linking signal transduction and actin polymerization. FASEB J. 16:487-499.
20. Katiyar, S. K., and T. D. Edlind. 2001. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med. Mycol. 39:109-116.
21. Kontoyiannis, D. P., and S. Rupp. 2000. Cyclic AMP and fluconazole resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 44:1743-1744.
22. Kraakman, L., K. Lemaire, P. Ma, A. W. R. H. Teunissen, M. C. V. Donaton, P. Van Dijek, J. Winderickx, J. H. de Winde, and J. M. Thevelein. 1999. A Saccharomyces cerevisiae G-protein coupled receptor, Gpr1, is specifically required for glucose activation of the cAMP pathway during the transition to growth on glucose. Mol. Microbiol. 32:1002-1012.
23. Krishnamurthy, S., V. Gupta, R. Prasad, S. L. Panwar, and R. Prasad. 1998. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs, and human steroid hormones. FEMS Microbiol. Lett. 160:191-197.
24. Marchetti, O., P. Moreillon, M. P. Glauser, J. Bille, and D. Sanglard. 2002. Potent synergism of the combination of fluconazole and cyclosporin in Candida albicans. Antimicrob. Agents Chemother. 44:2373-2381.
25. Mbonyi, K., L. V. Aelst, J. C. Arguelles, A. W. H. Jans, and J. M. Thevelein. 1990. Glucose-induced hyperaccumulation of cyclic AMP and defective glucose repression in yeast strains with reduced activity of cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 10:4518-4523.
26. Onyewu, C., J. R. Blankenship, M. Del Poeta, and J. Heitman. 2003. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47:956-964.
27. Orth, A. B., M. Rzhertskaya, E. J. Pell, and M. Tien. 1995. A serine (threonine) protein kinase confers fungicide resistance in the phytopathogenic fungus Ustilago maydis. Appl. Environ. Microbiol. 61:2341-2345.
28. Pan, X., and J. Heitman. 1999. Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:4874-4887.
29. Perea, S., J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to a azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
30. Ramesh, M. A., R. D. Laidlaw, F. Durrenberger, A. B. Orth, and J. W. Kronstad. 2001. The cAMP signal transduction pathway mediates resistance to dicarboximide and aromatic hydrocarbon fungicides in Ustilago maydis. Fungal Genet. Biol. 32:183-193.
31. Rohlff, C., and R. I. Glazer. 1995. Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell. Signal. 7:431-443.
32. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
33. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
34. Smith, W. L., and T. D. Edlind. 2002. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob. Agents Chemother. 46:3532-3539.
35. Thevelein, J. M., and J. H. de Winde. 1999. Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol. Microbiol. 33:904-918.
36. White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.